SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)

9 Months Ended

Sep. 30, 2018

Accounting Standards Update 2014-09 | Restatement of beginning balances

Summary of impacts of adoption of recent accounting pronouncements

		Balance at				Balance at
		December 31, 2017		Adjustment		January 1, 2018
Consolidated Balance Sheets
Assets
Inventories	$	337,216	$	(14,637)	$	322,579
Prepaid and other		109,791		13,984		123,775
Liabilities
Accounts payable and accrued liabilities		461,579		(5,706)		455,873
Deferred income taxes		20,995		1,292		22,287
Deferred and other non-current liabilities		5,608		824		6,432
Stockholders’ Equity
Retained earnings		1,301,147		2,937		1,304,084

Accounting Standards Update 2014-09 | Cumulative effect of change

Summary of impacts of adoption of recent accounting pronouncements

	For the Three Months Ended September 30, 2018
				Balances
				Without		Effect of
		As		Adoption of		Change
		Reported		ASC 606		Higher/(Lower)
Consolidated Statements of Income
Net Sales
Beauty + Home	$	341,760	$	340,787	$	973
Pharma		227,515		227,526		(11)
Food + Beverage		96,500		96,478		22
Costs and Expenses
Cost of sales (exclusive of depreciation and amortization)		435,379		434,601		778
Provision for income taxes		11,920		11,866		54
Net income		39,022		38,870		152

	For the Nine Months Ended September 30, 2018
				Balances
				Without		Effect of
		As		Adoption of		Change
		Reported		ASC 606		Higher/(Lower)
Consolidated Statements of Income
Net Sales
Beauty + Home	$	1,088,469	$	1,087,922	$	547
Pharma		698,851		699,299		(448)
Food + Beverage		292,413		292,437		(24)
Costs and Expenses
Cost of sales (exclusive of depreciation and amortization)		1,355,445		1,354,844		601
Provision for income taxes		52,966		53,138		(172)
Net income		154,091		154,445		(354)

	September 30, 2018
				Balances
				Without		Effect of
		As		Adoption of		Change
		Reported		ASC 606		Higher/(Lower)
Consolidated Balance Sheets
Assets
Inventories	$	394,264	$	409,502	$	(15,238)
Prepaid and other		118,613		102,767		15,846
Liabilities
Accounts payable and accrued liabilities		524,528		528,081		(3,553)
Deferred income taxes		48,857		47,737		1,120
Deferred and other non-current liabilities		24,837		24,379		458
Stockholders’ Equity
Retained earnings		1,345,851		1,343,268		2,583

Accounting Standards Update 2017-07

Summary of impacts of adoption of recent accounting pronouncements

	Original				Revised
	Balance		Adjustment		Balance
Revised Condensed Consolidated Statements of Income
Three Months Ended September 30, 2017
Cost of sales (exclusive of depreciation and amortization)	$	408,081	$	(300)	$	407,781
Selling, research & development and administrative		95,748		(212)		95,536
Total Operating Expenses		543,916		(512)		543,404
Operating Income		80,410		512		80,922
Miscellaneous, net		(2,200)		(512)		(2,712)
Total Other (Expense) Income		(10,892)		(512)		(11,404)
Income before Income Taxes		69,518		—		69,518
Nine Months Ended September 30, 2017
Cost of sales (exclusive of depreciation and amortization)	$	1,192,967	$	(838)	$	1,192,129
Selling, research & development and administrative		292,923		(649)		292,274
Total Operating Expenses		1,600,550		(1,487)		1,599,063
Operating Income		242,838		1,487		244,325
Miscellaneous, net		(509)		(1,487)		(1,996)
Total Other (Expense) Income		(24,272)		(1,487)		(25,759)
Income before Income Taxes		218,566		—		218,566